Extragonadal Teratoma
Watchlist
Retrieved
2021-01-23
Source
Trials
—
Genes
BCL10,
CTNNB1,
KIT,
STK11,
POU5F1,
NANOG,
SETBP1,
FGFR3,
POU5F1P4,
POU5F1P3,
ATN1,
SOX2,
IGHV1-12,
TP53,
TRRAP,
HSP90B1,
PLSCR4,
KLF4,
DMRT1,
AFP,
RPE65,
SRRM2,
GRN,
SLC22A3,
HDAC1,
KRAS,
CKAP4,
MYC,
PSMD10,
PTBP1
BCL10,
CTNNB1,
KIT,
STK11,
POU5F1,
NANOG,
SETBP1,
FGFR3,
POU5F1P4,
POU5F1P3,
ATN1,
SOX2,
IGHV1-12,
TP53,
TRRAP,
HSP90B1,
PLSCR4,
KLF4,
DMRT1,
AFP,
RPE65,
SRRM2,
GRN,
SLC22A3,
HDAC1,
KRAS,
CKAP4,
MYC,
PSMD10,
PTBP1,
TP63,
UVRAG,
PNO1,
RBMS3,
CDX2,
MAK16,
BMP2,
DND1,
LIN28A,
MSC,
NOG,
PRPF4,
TIPRL,
MBD2,
ATOH8,
PROM1,
FSD1L,
CREG1,
LHX2,
ZFP42,
REXO1,
NANOS3,
MVP,
UTF1,
GFI1B,
LBX1-AS1,
HMGA2,
XIST,
MIR367,
MIR373,
CHAC2,
MIR375,
SYCE1L,
NKX2-1,
PLAA,
KLF2,
KLHL1,
KAT5,
CHD7,
FBXW7,
LSM2,
IMP3,
MKS1,
ESRP1,
DDX4,
DCDC2,
GMNN,
DNMT3L,
GAS5,
TGFB1,
PRDM14,
FSD1,
METTL8,
CBX5,
SIRT1,
MESD,
TDGF1P6,
CBX3,
ASXL3,
ITFG1,
GADD45G,
HPSE,
NES,
TIMP1,
AAVS1,
TFAP2C,
ERCC1,
ABCC2,
CSE1L,
CSF2RA,
DAZL,
DHCR24,
EGR1,
ELF4,
ESR1,
TCF12,
GPC4,
FGF2,
FHIT,
FOXO3,
FMOD,
NR5A1,
FUT1,
CISH,
CDKN2B,
CDKN2A,
CDH1,
NR0B1,
ALPP,
ALPG,
BIRC5,
AQP4,
AR,
ATM,
BAX,
BCL2,
BRCA1,
BRAF,
CALD1,
CD1A,
CD34,
CDK1,
GABPA,
GATA2,
GATA6,
MRC1,
NHS,
NOTCH1,
PGM1,
PIN1,
PMAIP1,
PTEN,
RB1,
SLC3A2,
SLC5A5,
ACAT1,
SNAI1,
SNRPN,
SRY,
SSTR2,
ZEB1,
NFE2L2,
MMP9,
GDNF,
KITLG,
GFRA1,
GSTP1,
HIF1A,
MNX1,
HMGA1,
IL3,
JAG2,
KRT10,
KRT18,
LNPEP,
EPCAM,
MAT1A,
MCL1,
ME1,
MEFV,
PSC
Drugs
Allogeneic multi-virus specific T lymphocytes targeting BK virus, cytomegalovirus, human herpesvirus-6, Epstein Barr virus and adenovirus,
haematopoietic stem cells and blood progenitors umbilical cord-derived expanded with (1R, 4R)-N1-(2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine dihydrobromide dihydrate
Registered!
Extragonadal teratoma is an extremely rare, benign or malignant germ cell tumor characterized, clinically, by a teratoma presenting in an extragonadal location (e.g. retroperitoneum, mediastinum, craniofacial or sacrococcygeal region, intraosseous, solid organs) and, histologically, by displaying well-differentiated structures, as well as immature elements. Presenting symptoms are variable depending on size and location of tumor.